STSandra Trindade

Sandra Trindade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Trindade has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A platform for robust quantitative functional genomics reveals temporal fitness landscapes in African trypanosomes

    by Simon D’ARchivio, Lorenzo Brusini, Sandra Trindade, Luisa M Figueiredo, Catarina Gadelha, Bill Wickstead

    Genome-scale phenotypic screening is transforming our understanding of host-pathogen interactions, but accurate quantitation of mutant fitness and generation of libraries in strains that capture complex disease characteristics remains challenging. Here we introduce Direct RNAi Fragment Sequencing (DRiF-Seq), a sequencing-optimized high-throughput RNA-interference platform that enables robust, clone-resolved quantification of fitness effects in African trypanosomes. Combined with an a posteriori noise estimation approach, DRiF-Seq provides reproducible estimates of fitness magnitude, timing, and statistical confidence for individual mutants and genes. Application to pleomorphic bloodstream-form Trypanosoma brucei enables the first genome-scale quantitative profiling in a mammalian infection model, creating a framework for investigating parasite biology at scale in host. DRiF-Seq demonstrates that over half of core genes have a fitness cost when targetted by RNAi, accurately resolves fitness landscapes within molecular complexes, identifies characteristic temporal signatures of gene disruption, and detects biologically meaningful differences between closely related parasite strains that predict differential drug sensitivity. Comparative analyses with genome-wide datasets from Toxoplasma and Plasmodium further demonstrate conserved and lineage-specific determinants of parasite fitness across eukaryotes. Together, DRiF-Seq provides a sensitive and transferable framework for quantitative functional genomics, a community resource for understanding parasite biology and a system for exploitation of high-complexity mutant screens in host.


  • Open Access

    Trypanosoma brucei triggers a broad immune response in the adipose tissue

    by Henrique Machado, Tiago Bizarra-Rebelo, Mariana Costa-Sequeira, Sandra Trindade, Tânia Carvalho, Filipa Rijo-Ferreira, Barbara Rentroia-Pacheco, Karine Serre, Luisa M. Figueiredo

    Adipose tissue is one of the major reservoirs of Trypanosoma brucei parasites, the causative agent of sleeping sickness, a fatal disease in humans. In mice, the gonadal adipose tissue (AT) typically harbors 2–5 million parasites, while most solid organs show 10 to 100-fold fewer parasites. In this study, we tested whether the AT environment responds immunologically to the presence of the parasite. Transcriptome analysis of T. brucei infected adipose tissue revealed that most upregulated host genes are involved in inflammation and immune cell functions. Histochemistry and flow cytometry confirmed an increasingly higher number of infiltrated macrophages, neutrophils and CD4+ and CD8+ T lymphocytes upon infection. A large proportion of these lymphocytes effectively produce the type 1 effector cytokines, IFN-γ and TNF-α. Additionally, the adipose tissue showed accumulation of antigen-specific IgM and IgG antibodies as infection progressed. Mice lacking T and/or B cells (Rag2-/-, Jht-/-), or the signature cytokine (Ifng-/-) displayed a higher parasite load both in circulation and in the AT, demonstrating the key role of the adaptive immune system in both compartments. Interestingly, infections of C3-/- mice showed that while complement system is dispensable to control parasite load in the blood, it is necessary in the AT and other solid tissues. We conclude that T. brucei infection triggers a broad and robust immune response in the AT, which requires the complement system to locally reduce parasite burden.


  • Open Access

    Tissue tropism in parasitic diseases

    by Sara Silva Pereira, Sandra Trindade, Mariana De Niz, Luisa M. Figueiredo

    Parasitic diseases, such as sleeping sickness, Chagas disease and malaria, remain a major cause of morbidity and mortality worldwide, but particularly in tropical, developing countries. Controlling these diseases requires a better understanding of host–parasite interactions, including a deep appreciation of parasite distribution in the host. The preferred accumulation of parasites in some tissues of the host has been known for many years, but recent technical advances have allowed a more systematic analysis and quantifications of such tissue tropisms. The functional consequences of tissue tropism remain poorly studied, although it has been associated with important aspects of disease, including transmission enhancement, treatment failure, relapse and clinical outcome. Here, we discuss current knowledge of tissue tropism in Trypanosoma infections in mammals, describe potential mechanisms of tissue entry, comparatively discuss relevant findings from other parasitology fields where tissue tropism has been extensively investigated, and reflect on new questions raised by recent discoveries and their potential impact on clinical treatment and disease control strategies.


  • Open Access

    Trypanosoma brucei triggers a marked immune response in male reproductive organs

    by Tânia Carvalho, Sandra Trindade, Sílvia Pimenta, Ana B Santos, Filipa Rijo-Ferreira, Luísa M Figueiredo

    African trypanosomiasis is caused by the protozoan parasite Trypanosoma brucei, transmitted between mammals by the bite of a tsetse. It has been recently shown that parasites accumulate in large numbers in various organs and tissues, including the mouse testis. Whether parasites are protected from the immune system in the male reproductive organ or can be transmitted through sexual route remains unknown. Here we show that parasites can be detected by fine needle aspiration cytology of the male reproductive system in mice, and histopathological analysis revealed that T. brucei accumulates in the stroma of the epididymis, epididymal adipose tissue and fibrous tunics of the testis. No parasites were found in the lumen of intact epididymal ducts or seminiferous tubules of the testis, indicating that the large majority of the parasites are not located in immune-privileged sites. In fact, these parasites are associated with marked inflammatory cell infiltration, parasite degeneration, and severe tissue damage and rupture of epididymal ducts, which may be related with reduced fertility. Overall, we show that just like in the bloodstream and most other tissues, in the male reproductive organs, T. brucei are exposed to a strong immune response. The detection of a very high number of parasites in this organ and its accessibility opens the possibility of using fine needle aspiration cytology as a complementary diagnostic tool in Animal African Trypanosomiasis. The protozoan parasite Trypanosoma brucei is the causative agent of African trypanosomiasis in humans (sleeping sickness) and animals (nagana). In male animals, natural infection is commonly associated with decreased fertility but the causes for this condition remain poorly understood. Interestingly, in mouse experimental infections, parasites accumulate in the male reproductive organs. Here we show that these parasites are not protected by the tissues’ specialized barriers. As a result, parasites elicit a severe immune response that leads to parasite elimination, but also causes damage to the host tissues. This damage may be associated with reduced fertility in naturally infected animals and may also hinder treatment. Moreover, the presence of large numbers of parasites in an organ that is easily accessible by aspiration cytology could provide for a novel diagnostic tool in Animal African Trypanosomiasis.


  • Faculty Opinions recommendation of Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure.

    by Luisa Figueiredo, Sandra Trindade

    Trypanosoma cruzi is the causative agent of Chagas disease, one of the biggest public health problems, mainly in Latin America. The disease evolves in two stages. The chronic stage can last several years and, during this time, parasites are essentially undetectable in circulation and appear to persist mainly in the heart and digestive muscles. The efficacy of current drug treatment is not always 100% and the reasons for relapses...

  • Top Cited Papers
    Open Access

    Trypanosoma brucei Parasites Occupy and Functionally Adapt to the Adipose Tissue in Mice

    by Sandra Trindade, Filipa Rijo-Ferreira, Tânia Carvalho, Daniel Pinto-Neves, Fabien Guegan, Francisco Aresta-Branco, Fabio Bento, Simon A. Young, Andreia Pinto, Jan Van Den Abbeele, et al.


  • Open Access

    Multiple Resistance at No Cost: Rifampicin and Streptomycin a Dangerous Liaison in the Spread of Antibiotic Resistance

    by Paulo Durão, Sandra Trindade, Ana Sousa, Isabel Gordo

    Evidence is mounting that epistasis is widespread among mutations. The cost of carrying two deleterious mutations, or the advantage of acquiring two beneficial alleles, is typically lower that the sum of their individual effects. Much less is known on epistasis between beneficial and deleterious mutations, even though this is key to the amount of genetic hitchhiking that may occur during evolution. This is particularly important in the context of antibiotic resistance: Most resistances are deleterious, but some can be beneficial and remarkably rifampicin resistance can emerge de novo in populations evolving without antibiotics. Here we show pervasive positive pairwise epistasis on Escherichia coli fitness between beneficial mutations, which confer resistance to rifampicin, and deleterious mutations, which confer resistance to streptomycin. We find that 65% of double resistant strains outcompete sensitive bacteria in an environment devoid of antibiotics. Weak beneficial mutations may therefore overcome strong deleterious mutations and can even render double mutants strong competitors.


  • ANTIBIOTIC RESISTANCE AND STRESS IN THE LIGHT OF FISHER'S MODEL

    by Sandra Trindade, Ana Sousa, Isabel Gordo

    The role of mutations in evolution depends upon the distribution of their effects on fitness. This distribution is likely to depend on the environment. Indeed genotype-by-environment interactions are key for the process of local adaptation and ecological specialization. An important trait in bacterial evolution is antibiotic resistance, which presents a clear case of change in the direction of selection between environments with and without antibiotics. Here, we study the distribution of fitness effects of mutations, conferring antibiotic resistance to Escherichia coli, in benign and stressful environments without drugs. We interpret the distributions in the light of a fitness landscape model that assumes a single fitness peak. We find that mutation effects (s) are well described by a shifted gamma distribution, with a shift parameter that reflects the distance to the fitness peak and varies across environments. Consistent with the theoretical predictions of Fisher's geometrical model, with a Gaussian relationship between phenotype and fitness, we find that the main effect of stress is to increase the variance in s. Our findings are in agreement with the results of a recent meta-analysis, which suggest that a simple fitness landscape model may capture the variation of mutation effects across species and environments.


  • Open Access

    Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations

    by Rui F. Silva, Sílvia C. M. Mendonça, Luís M. Carvalho, Ana M. Reis, Isabel Gordo, Sandra Trindade, Francisco Dionisio

    Multidrug-resistant bacteria arise mostly by the accumulation of plasmids and chromosomal mutations. Typically, these resistant determinants are costly to the bacterial cell. Yet, recently, it has been found that, in Escherichia coli bacterial cells, a mutation conferring resistance to an antibiotic can be advantageous to the bacterial cell if another antibiotic-resistance mutation is already present, a phenomenon called sign epistasis. Here we study the interaction between antibiotic-resistance chromosomal mutations and conjugative (i.e., self-transmissible) plasmids and find many cases of sign epistasis (40%)—including one of reciprocal sign epistasis where the strain carrying both resistance determinants is fitter than the two strains carrying only one of the determinants. This implies that the acquisition of an additional resistance plasmid or of a resistance mutation often increases the fitness of a bacterial strain already resistant to antibiotics. We further show that there is an overall antagonistic interaction between mutations and plasmids (52%). These results further complicate expectations of resistance reversal by interdiction of antibiotic use. Bacteria can become resistant to antibiotics by spontaneous mutation of chromosomal genes or through the acquisition of horizontally mobile genetic elements, mainly conjugative plasmids. Plasmid-borne resistance is widespread among bacterial pathogens. Plasmids generally entail a cost to the host, associated with the replication and maintenance of the genetic element and with the expression of its genes. Therefore, in the absence of antibiotic, both plasmids and resistance mutations are often deleterious and confer a fitness cost to the cell. Here we studied epistatic interactions between five natural conjugative plasmids and ten chromosomal mutations conferring resistance to three types of antibiotics, making a total of 50 different combinations of chromosomal mutations and conjugative plasmids. We show that sometimes plasmids confer an advantage to bacterial strains carrying resistance mutations in their chromosome. This occurs in 32% (16 out of 50) of tested combinations. Furthermore, in 5 out of 50 plasmid-mutations combinations studied (10%), we observed an increased fitness when a plasmid-bearing bacterial cell acquires a drug-resistant mutation. These examples of sign epistasis are highly unexpected. This work explains, at least in part, how multidrug resistance evolved so rapidly.


  • Rate and effects of spontaneous mutations that affect fitness in mutator Escherichia coli

    by Sandra Trindade, Lilia Perfeito, Isabel Gordo

    Knowledge of the mutational parameters that affect the evolution of organisms is of key importance in understanding the evolution of several characteristics of many natural populations, including recombination and mutation rates. In this study, we estimated the rate and mean effect of spontaneous mutations that affect fitness in a mutator strain of Escherichia coli and review some of the estimation methods associated with mutation accumulation (MA) experiments. We performed an MA experiment where we followed the evolution of 50 independent mutator lines that were subjected to repeated bottlenecks of a single individual for approximately 1150 generations. From the decline in mean fitness and the increase in variance between lines, we estimated a minimum mutation rate to deleterious mutations of 0.005 (±0.001 with 95% confidence) and a maximum mean fitness effect per deleterious mutation of 0.03 (±0.01 with 95% confidence). We also show that any beneficial mutations that occur during the MA experiment have a small effect on the estimate of the rate and effect of deleterious mutations, unless their rate is extremely large. Extrapolating our results to the wild-type mutation rate, we find that our estimate of the mutational effects is slightly larger and the inferred deleterious mutation rate slightly lower than previous estimates obtained for non-mutator E. coli .